Previous close | 16.00 |
Open | 17.10 |
Bid | 16.30 |
Ask | 18.30 |
Strike | 190.00 |
Expiry date | 2025-01-17 |
Day's range | 17.10 - 17.61 |
Contract range | N/A |
Volume | |
Open interest | 303 |
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.